TY - JOUR TI - Systematic review of basic oral care for the management of oral mucositis in cancer patients and clinical practice guidelines AU - Hong, C.H.L. AU - Gueiros, L.A. AU - Fulton, J.S. AU - Cheng, K.K.F. AU - Kandwal, A. AU - Galiti, D. AU - Fall-Dickson, J.M. AU - Johansen, J. AU - Ameringer, S. AU - Kataoka, T. AU - Weikel, D. AU - Eilers, J. AU - Ranna, V. AU - Vaddi, A. AU - Lalla, R.V. AU - Bossi, P. AU - Elad, S. AU - On behalf of the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society for Oral Oncology (MASCC/ISOO) JO - Supportive Care in Cancer PY - 2019 VL - 27 TODO - 10 SP - 3949-3967 PB - Springer-Verlag SN - 0941-4355, 1433-7339 TODO - 10.1007/s00520-019-04848-4 TODO - bicarbonate; chlorhexidine; sodium chloride, Article; cancer chemotherapy; cancer patient; cancer radiotherapy; dental procedure; head and neck cancer; hematopoietic stem cell transplantation; human; meta analysis; mouth hygiene; oral mucositis; patient education; practice guideline; priority journal; systematic review; methodology; mucosa inflammation; neoplasm; oncology; procedures; stomatitis, Dental Care; Humans; Medical Oncology; Mucositis; Neoplasms; Practice Guidelines as Topic; Research Design; Stomatitis TODO - Purpose: The aim of this study was to update the clinical practice guidelines for the use of basic oral care (BOC) interventions for the prevention and/or treatment of oral mucositis (OM). Methods: A systematic review was conducted by the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society for Oral Oncology (MASCC/ISOO). The body of evidence for each intervention in each cancer treatment setting was assigned an evidence level. The findings were added to the database used to develop the 2013 MASCC/ISOO clinical practice guidelines. Based on the evidence level, one of the following three guideline determinations was possible: Recommendation, Suggestion, No guideline possible. Results: A total of 17 new papers across six interventions were examined and merged with a previous database. Based on the literature, the following guidelines were possible. The panel suggests that the implementation of multi-agent combination oral care protocols is beneficial for the prevention of OM during chemotherapy, head and neck (H&N) radiation therapy (RT), and hematopoietic stem cell transplantation (Level of Evidence III). The panel suggests that chlorhexidine not be used to prevent OM in patients undergoing H&N RT (Level of Evidence III). No guideline was possible for professional oral care, patient education, saline, and sodium bicarbonate, and expert opinion complemented these guidelines. Conclusions: The evidence supports the use of multi-agent combination oral care protocols in the specific populations listed above. Additional well-designed research is needed on the other BOC interventions prior to guideline formulation. © 2019, Springer-Verlag GmbH Germany, part of Springer Nature. ER -